Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 07-2007 | 04-2007 | 01-2007 | 10-2006 | 07-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 920 | 29 | 427 | 1,285 | 7 |
| Receivables | 35 | 10 | 5 | 13 | N/A |
| TOTAL | $983 | $47 | $438 | $1,299 | $7 |
| Non-Current Assets | |||||
| PPE Net | 2,207 | 2,393 | 2,037 | 1,420 | 1,107 |
| TOTAL | $2,207 | $2,393 | $2,037 | $1,420 | $1,107 |
| Total Assets | $3,191 | $2,439 | $2,475 | $2,719 | $1,114 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4 | 22 | 0 | 2 | 19 |
| Accrued Expenses | 5 | 3 | 20 | 13 | 5 |
| Other current liabilities | N/A | 24 | N/A | 13 | N/A |
| TOTAL | $514 | $99 | $21 | $2,015 | $24 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $514 | $99 | $21 | $2,015 | $24 |
| Shareholders' Equity | |||||
| Common Shares | 24 | 22 | 22 | 18 | 18 |
| Retained earnings | -2,348 | -1,208 | -837 | -584 | -180 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -1 |
| TOTAL | $2,676 | $2,340 | $2,455 | $705 | $1,090 |
| Total Liabilities And Equity | $3,191 | $2,439 | $2,475 | $2,719 | $1,114 |